RPA: A Protein Involved in DNA Replication and Associated with Diseases

Target Name: Replication Protein A Complex (RPA)

NCBI ID: P34676

Replication Protein A Complex (RPA)

Other Name(s): RPA | RPA complex

RPA: A Protein Involved in DNA Replication and Associated with Diseases

Replication Protein A Complex (RPA) is a protein that plays a crucial role in the process of DNA replication. It is a large protein complex that contains several subunits, including the protein itself, DNA polymerase, and several non-polymorphic proteins. RPA is involved in the regulation of DNA replication, including the proper assembly and disassembly of the DNA replication complex.

One of the unique features of RPA is its ability to interact with the double helix. It can form a stable complex with DNA, allowing it to participate in the process of DNA replication. This interaction between RPA and DNA allows it to play a critical role in the regulation of DNA replication.

In addition to its role in DNA replication, RPA has also been shown to play a potential drug target (5) or biomarker (6) in several diseases.

Disease association
-----------------

RPA has been associated with several diseases, including cancer, neurodegenerative diseases, and systemic diseases.

One of the most well-known associations is with the neurodegenerative disease, Alzheimer's disease. RPA has been shown to be involved in the development and progression of Alzheimer's disease, and may play a role in the regulation of neurodegeneration.

Another disease associated with RPA is cancer. RPA has been shown to be involved in the regulation of DNA replication in cancer cells, and may be a potential target for cancer treatments.

Another potential association with RPA is neurodegenerative diseases, such as Parkinson's disease and Huntington's disease. These diseases are characterized by the progressive loss of motor and cognitive function, and RPA has been shown to be involved in the regulation of the replacement of damaged DNA in these diseases.

In addition to these diseases, RPA has also been associated with several other conditions, including systemic lupus erythematosus and rheumatoid arthritis.

Drug targeting
--------------

Given its involvement in the regulation of DNA replication, RPA has been considered as a potential drug target. Several studies have shown that blocking RPA can lead to therapeutic effects in these diseases, including the regulation of neurodegeneration (13), the inhibition of cancer cell proliferation (14), and the improvement of cognitive function.

One of the most well-known drugs that targets RPA is the drug lenopti. Lenopti is a small molecule that inhibits the activity of RPA, and has been shown to improve cognitive function in animal models of Alzheimer's disease.

Another drug that targets RPA is the drug ATP-222, which is a peptide that blocks the activity of RPA and has been shown to improve motor function in patients with Alzheimer's disease.

Biomarker
-----------

In addition to its potential as a drug target, RPA has also been shown to be a potential biomarker for several diseases.

One of the most well-known uses of RPA as a biomarker is its ability to interact with the double helix. This interaction allows RPA to participate in the regulation of DNA replication, and can be used as a marker for the diagnosis and monitoring of DNA replication disorders.

Another use of RPA as a biomarker is its involvement in the regulation of neurodegeneration. RPA has been shown to be involved in the regulation of the replacement of damaged DNA in neurodegenerative diseases, and its levels have been shown to be decreased in these diseases.

Conclusion
----------

Replication Protein A Complex (RPA) is a protein that plays a critical role in the process of DNA replication and has been associated with several diseases, including cancer, neurodegenerative diseases, and systemic diseases. Its ability to interact with the double

Protein Name: Replication Protein A Complex (RPA)

The "Replication Protein A Complex (RPA) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Replication Protein A Complex (RPA) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets